Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alexion Pharmaceuticals (NQ: ALXN )

156.70 USD +0.05 (+0.03%)
Official Closing Price Updated: 5:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Alexion Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CHNG, RP, RNET, MDCA, NK; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GH EPIX CELH
From Benzinga
My Top 3 Large-Cap Stocks to Own in 2021
Dividends and increasing revenue mean you can count on these companies for safety and growth. 
Tags Market News TGT ABT
From Motley Fool
5 Large-Cap Stocks That'll Make You Richer in 2021
Sometimes, bigger really is better. 
Tags AZN ALXN VRTX
From Motley Fool
SHAREHOLDER ALERT: WeissLaw LLP Reminds MTSC, IPHI, ALXN and XLNX Shareholders About Its Ongoing Investigations
From PR Newswire
Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab) in Hospitalized Patients with Severe COVID-19 
From Business Wire News Releases
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference 
From Business Wire News Releases
Better Coronavirus Stock: AstraZeneca vs. Pfizer
Here's how these two huge COVID-19 vaccine makers compare. 
Tags PFE VTRS ALXN
From Motley Fool
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALXN, MGLN, FLIR, BEAT; Shareholders Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
Is AstraZeneca Stock a Buy?
The pharmaceutical giant has an effective coronavirus vaccine and a multibillion-dollar acquisition in the works -- but does it have all the earnings-growth drivers it needs? 
Tags AZN ALXN PFE
From Motley Fool
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations
From PR Newswire
3 Top Stocks That'll Make You Richer in January (and Beyond)
These great companies can help you kick off 2021 with a bang. 
Tags GDDY Market News AG
From Motley Fool
Alexion to Present at the 39th Annual J.P. Morgan Healthcare Conference
Alexion to Present at the 39th Annual J.P. Morgan Healthcare Conference 
From Business Wire News Releases
ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
Notable ETF Inflow Detected - RSP, ALXN, ABMD, FTNT
Symbols mentioned in this story: RSP, ALXN, ABMD, FTNT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
4 Reasons to Buy AstraZeneca Stock Now
It's a great pharmaceutical company right now, but probably not for the reasons you think. 
Tags Market News ALXN AZN
From Motley Fool
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages RP, MDCA, ALXN, SPWH Shareholders to Contact the Firm
From GlobeNewswire News Releases
12 Stocks Turned $10,000 Into $1.1 Million In 12 Months
It's been quite a year of contrasts for investors. Own the wrong S&P 500 stocks and you lose billions, but huge gains were there for the taking, too. 
From Investor's Business Daily
WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing Investigations
From PR Newswire
Alexion Pharmaceuticals Now #196 Largest Company, Surpassing Paychex
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Alexion Pharmaceuticals Inc. (ALXN) has taken over the #196 spot from Paychex Inc (PAYX),... 
Tags Stocks
From Market News Video
PreMarket Prep Stock Of The Day: AstraZeneca
Benzinga'sPreMarket Prepairs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders ... 
Tags vaccine Health Care Coronavirus
From Benzinga
Noteworthy ETF Inflows: RSP, ALXN, FTNT, ABMD
Symbols mentioned in this story: RSP, ALXN, FTNT, ABMD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Could AstraZeneca's COVID Vaccine Still Succeed?
The short answer: Yes. 
Tags Market News AZN ALXN
From Motley Fool
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers - ALXN, TCF, CATM, TCP
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – PNM, ALXN, HMSY
From GlobeNewswire News Releases
Are These The Best Biotech Stocks To Buy This Week? 3 Names To Know
Tags Market News
From Stockmarket.com
SHAREHOLDER ALERT: WeissLaw LLP Reminds TCF and ALXN Shareholders About Its Ongoing Investigations
From PR Newswire
Should Investors Consider This Biotech Takeover Target?
Getting in on the extensive merger and acquisition game of large pharmaceutical companies is the ultimate endgame for Exelixis, a biotech that already boasts an established cancer-focused product... 
Tags MRK EXEL GILD
From Motley Fool
Is AstraZeneca Paying Too Much for Alexion?
Dig a little deeper into the valuation. 
Tags AZN ALXN Market News
From Motley Fool
3 Biotech Stocks That Could Explode Higher in 2021
Here's how three nascent drugmakers could make 2021 a banner year for your portfolio. 
Tags Market News ARGX CRSP
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.